(Q40469926)

20 September 2017

1 reference

title

Screening, early detection, and treatment of prostate cancer: a European view. (English)

1 reference

20 September 2017

Schröder FH

1

1 reference

PubMed ID

7653022

20 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

20 September 2017

1 reference

20 September 2017

46

1 reference

20 September 2017

3 Suppl A

1 reference

20 September 2017

62-70

1 reference

Ethics of a prostate cancer screening trial.

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng./ml

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Screening for prostate cancer--necessity or nonsense?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Cancer statistics, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Changes in prostate cancer incidence and treatment in USA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

High 10-year survival rate in patients with early, untreated prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

A critique of the decision analysis for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Screening for prostate cancer. A decision analytic view

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Modalities available for screening for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Cancer in the European community and its member states

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Recent results of management of palpable clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Radical prostatectomy for high grade disease: a reevaluation 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Where treatment may be necessary and possible

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Characteristics of prostate cancer found with early detection regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

Prostate cancer: to screen or not to screen?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980252-0

7 January 2021

10.1016/S0090-4295(99)80252-0

Identifiers

DOI

1 reference

release_nmojze22hnd3zdvfgt2vqabcjy

20 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nmojze22hnd3zdvfgt2vqabcjy

24 November 2022

mapped directly with Wikidata item

PubMed ID

7653022

1 reference

PubMed ID

7653022